Bone Health Technologies’ Osteoboost Cleared by FDA
The wearable device is indicated to reduce bone strength and density decline in postmenopausal women and is designed to improve bone health during osteopenia.
The U.S. Food and Drug Administration (FDA) has granted clearance for Bone Health Technologies’ Osteoboost, a non-pharmacological device-based prescription treatment for postmenopausal women diagnosed with osteopenia (low bone density).
